Leader
|
|
|
00000nz a2200037n 45 0 |
001
|
|
|
WKP|Q59115171
(VIAF cluster)
(Authority/Source Record)
|
003
|
|
|
WKP |
005
|
|
|
20241121000239.0 |
008
|
|
|
241121nneanz||abbn n and d |
035
|
|
|
‡a
(WKP)Q59115171
|
024
|
|
|
‡a
0000-0002-3665-7106
‡2
orcid
|
024
|
|
|
‡a
28268038100
‡2
scopus
|
035
|
|
|
‡a
(OCoLC)Q59115171
|
100
|
0 |
|
‡a
Anthal I.P.M. Smits
‡c
researcher ORCID ID = 0000-0002-3665-7106
‡9
en
|
400
|
0 |
|
‡a
Anthal I.P.M. Smits
‡c
wetenschapper
‡9
nl
|
670
|
|
|
‡a
Author's A mesofluidics-based test platform for systematic development of scaffolds for in situ cardiovascular tissue engineering.
|
670
|
|
|
‡a
Author's Biomaterial-driven in situ cardiovascular tissue engineering-a multi-disciplinary perspective.
|
670
|
|
|
‡a
Author's Can We Grow Valves Inside the Heart? Perspective on Material-based In Situ Heart Valve Tissue Engineering.
|
670
|
|
|
‡a
Author's Cyclic Strain Affects Macrophage Cytokine Secretion and Extracellular Matrix Turnover in Electrospun Scaffolds
|
670
|
|
|
‡a
Author's Decoupling the Effect of Shear Stress and Stretch on Tissue Growth and Remodeling in a Vascular Graft
|
670
|
|
|
‡a
Author's Development of Non-Cell Adhesive Vascular Grafts Using Supramolecular Building Blocks.
|
670
|
|
|
‡a
Author's Differential Leaflet Remodeling of Bone Marrow Cell Pre-Seeded Versus Nonseeded Bioresorbable Transcatheter Pulmonary Valve Replacements
|
670
|
|
|
‡a
Author's Differential response of endothelial and endothelial colony forming cells on electrospun scaffolds with distinct microfiber diameters.
|
670
|
|
|
‡a
Author's Early in-situ cellularization of a supramolecular vascular graft is modified by synthetic stromal cell-derived factor-1α derived peptides.
|
670
|
|
|
‡a
Author's Ex vivo culture platform for assessment of cartilage repair treatment strategies.
|
670
|
|
|
‡a
Author's Hemodynamic loads distinctively impact the secretory profile of biomaterial-activated macrophages - implications for in situ vascular tissue engineering
|
670
|
|
|
‡a
Author's Host Response and Neo-Tissue Development during Resorption of a Fast Degrading Supramolecular Electrospun Arterial Scaffold
|
670
|
|
|
‡a
Author's Human In Vitro Model Mimicking Material-Driven Vascular Regeneration Reveals How Cyclic Stretch and Shear Stress Differentially Modulate Inflammation and Matrix Deposition
|
670
|
|
|
‡a
Author's In situ heart valve tissue engineering using a bioresorbable elastomeric implant - From material design to 12 months follow-up in sheep.
|
670
|
|
|
‡a
Author's In Situ Tissue Engineering of Functional Small-Diameter Blood Vessels by Host Circulating Cells Only.
|
670
|
|
|
‡a
Author's In Situ Tissue Engineering: Seducing the Body to Regenerate
|
670
|
|
|
‡a
Author's Layer-specific cell differentiation in bi-layered vascular grafts under flow perfusion
|
670
|
|
|
‡a
Author's Macrophage-Driven Biomaterial Degradation Depends on Scaffold Microarchitecture
|
670
|
|
|
‡a
Author's Modulation of macrophage phenotype and protein secretion via heparin-IL-4 functionalized supramolecular elastomers.
|
670
|
|
|
‡a
Author's Probing Single-Cell Macrophage Polarization and Heterogeneity Using Thermo-Reversible Hydrogels in Droplet-Based Microfluidics
|
670
|
|
|
‡a
Author's Shear flow affects selective monocyte recruitment into MCP-1-loaded scaffolds
|
670
|
|
|
‡a
Author's Sheep-Specific Immunohistochemical Panel for the Evaluation of Regenerative and Inflammatory Processes in Tissue-Engineered Heart Valves
|
670
|
|
|
‡a
Author's Synergistic protein secretion by mesenchymal stromal cells seeded in 3D scaffolds and circulating leukocytes in physiological flow.
|
670
|
|
|
‡a
Author's The degradation and performance of electrospun supramolecular vascular scaffolds examined upon in vitro enzymatic exposure
|
670
|
|
|
‡a
Author's Then and now: hypes and hopes of regenerative medicine.
|
670
|
|
|
‡a
Author's Tissue engineering meets immunoengineering: Prospective on personalized in situ tissue engineering strategies
|
670
|
|
|
‡a
Author's Tissue engineering of heart valves: advances and current challenges.
|
909
|
|
|
‡a
(scopus) 28268038100
‡9
1
|
909
|
|
|
‡a
(orcid) 0000000236657106
‡9
1
|
919
|
|
|
‡a
tissueengineeringofheartvalvesadvancesandcurrentchallenges
‡A
Tissue engineering of heart valves: advances and current challenges.
‡9
1
|
919
|
|
|
‡a
tissueengineeringmeetsimmunoengineeringprospectiveonpersonalizedinsitutissueengineeringstrategies
‡A
Tissue engineering meets immunoengineering: Prospective on personalized in situ tissue engineering strategies
‡9
1
|
919
|
|
|
‡a
thenandnowhypesandhopesofregenerativemedicine
‡A
Then and now: hypes and hopes of regenerative medicine.
‡9
1
|
919
|
|
|
‡a
degradationandperformanceofelectrospunsupramolecularvascularscaffoldsexamineduponinvitroenzymaticexposure
‡A
The degradation and performance of electrospun supramolecular vascular scaffolds examined upon in vitro enzymatic exposure
‡9
1
|
919
|
|
|
‡a
synergisticproteinsecretionbymesenchymalstromalcellsseededin3dscaffoldsandcirculatingleukocytesinphysiologicalflow
‡A
Synergistic protein secretion by mesenchymal stromal cells seeded in 3D scaffolds and circulating leukocytes in physiological flow.
‡9
1
|
919
|
|
|
‡a
sheepspecificimmunohistochemicalpanelfortheevaluationofregenerativeandinflammatoryprocessesintissueengineeredheartvalves
‡A
Sheep-Specific Immunohistochemical Panel for the Evaluation of Regenerative and Inflammatory Processes in Tissue-Engineered Heart Valves
‡9
1
|
919
|
|
|
‡a
shearflowaffectsselectivemonocyterecruitmentintomcp1loadedscaffolds
‡A
Shear flow affects selective monocyte recruitment into MCP-1-loaded scaffolds
‡9
1
|
919
|
|
|
‡a
probingsinglecellmacrophagepolarizationandheterogeneityusingthermoreversiblehydrogelsindropletbasedmicrofluidics
‡A
Probing Single-Cell Macrophage Polarization and Heterogeneity Using Thermo-Reversible Hydrogels in Droplet-Based Microfluidics
‡9
1
|
919
|
|
|
‡a
modulationofmacrophagephenotypeandproteinsecretionviaheparinil4functionalizedsupramolecularelastomers
‡A
Modulation of macrophage phenotype and protein secretion via heparin-IL-4 functionalized supramolecular elastomers.
‡9
1
|
919
|
|
|
‡a
macrophagedrivenbiomaterialdegradationdependsonscaffoldmicroarchitecture
‡A
Macrophage-Driven Biomaterial Degradation Depends on Scaffold Microarchitecture
‡9
1
|
919
|
|
|
‡a
layerspecificcelldifferentiationinbilayeredvasculargraftsunderflowperfusion
‡A
Layer-specific cell differentiation in bi-layered vascular grafts under flow perfusion
‡9
1
|
919
|
|
|
‡a
insitutissueengineeringseducingthebodytoregenerate
‡A
In Situ Tissue Engineering: Seducing the Body to Regenerate
‡9
1
|
919
|
|
|
‡a
insitutissueengineeringoffunctionalsmalldiameterbloodvesselsbyhostcirculatingcellsonly
‡A
In Situ Tissue Engineering of Functional Small-Diameter Blood Vessels by Host Circulating Cells Only.
‡9
1
|
919
|
|
|
‡a
insituheartvalvetissueengineeringusingabioresorbableelastomericimplantfrommaterialdesignto12monthsfollowupinsheep
‡A
In situ heart valve tissue engineering using a bioresorbable elastomeric implant - From material design to 12 months follow-up in sheep.
‡9
1
|
919
|
|
|
‡a
humaninvitromodelmimickingmaterialdrivenvascularregenerationrevealshowcyclicstretchandshearstressdifferentiallymodulateinflammationandmatrixdeposition
‡A
Human In Vitro Model Mimicking Material-Driven Vascular Regeneration Reveals How Cyclic Stretch and Shear Stress Differentially Modulate Inflammation and Matrix Deposition
‡9
1
|
919
|
|
|
‡a
hostresponseandneotissuedevelopmentduringresorptionofafastdegradingsupramolecularelectrospunarterialscaffold
‡A
Host Response and Neo-Tissue Development during Resorption of a Fast Degrading Supramolecular Electrospun Arterial Scaffold
‡9
1
|
919
|
|
|
‡a
hemodynamicloadsdistinctivelyimpactthesecretoryprofileofbiomaterialactivatedmacrophagesimplicationsforinsituvasculartissueengineering
‡A
Hemodynamic loads distinctively impact the secretory profile of biomaterial-activated macrophages - implications for in situ vascular tissue engineering
‡9
1
|
919
|
|
|
‡a
exvivocultureplatformforassessmentofcartilagerepairtreatmentstrategies
‡A
Ex vivo culture platform for assessment of cartilage repair treatment strategies.
‡9
1
|
919
|
|
|
‡a
earlyinsitucellularizationofasupramolecularvasculargraftismodifiedbysyntheticstromalcellderivedfactor1αderivedpeptides
‡A
Early in-situ cellularization of a supramolecular vascular graft is modified by synthetic stromal cell-derived factor-1α derived peptides.
‡9
1
|
919
|
|
|
‡a
differentialresponseofendothelialandendothelialcolonyformingcellsonelectrospunscaffoldswithdistinctmicrofiberdiameters
‡A
Differential response of endothelial and endothelial colony forming cells on electrospun scaffolds with distinct microfiber diameters.
‡9
1
|
919
|
|
|
‡a
differentialleafletremodelingofbonemarrowcellpreseededversusnonseededbioresorbabletranscatheterpulmonaryvalvereplacements
‡A
Differential Leaflet Remodeling of Bone Marrow Cell Pre-Seeded Versus Nonseeded Bioresorbable Transcatheter Pulmonary Valve Replacements
‡9
1
|
919
|
|
|
‡a
developmentofnoncelladhesivevasculargraftsusingsupramolecularbuildingblocks
‡A
Development of Non-Cell Adhesive Vascular Grafts Using Supramolecular Building Blocks.
‡9
1
|
919
|
|
|
‡a
decouplingtheeffectofshearstressandstretchontissuegrowthandremodelinginavasculargraft
‡A
Decoupling the Effect of Shear Stress and Stretch on Tissue Growth and Remodeling in a Vascular Graft
‡9
1
|
919
|
|
|
‡a
cyclicstrainaffectsmacrophagecytokinesecretionandextracellularmatrixturnoverinelectrospunscaffolds
‡A
Cyclic Strain Affects Macrophage Cytokine Secretion and Extracellular Matrix Turnover in Electrospun Scaffolds
‡9
1
|
919
|
|
|
‡a
canwegrowvalvesinsidetheheartperspectiveonmaterialbasedinsituheartvalvetissueengineering
‡A
Can We Grow Valves Inside the Heart? Perspective on Material-based In Situ Heart Valve Tissue Engineering.
‡9
1
|
919
|
|
|
‡a
biomaterialdriveninsitucardiovasculartissueengineeringamultidisciplinaryperspective
‡A
Biomaterial-driven in situ cardiovascular tissue engineering-a multi-disciplinary perspective.
‡9
1
|
919
|
|
|
‡a
mesofluidicsbasedtestplatformforsystematicdevelopmentofscaffoldsforinsitucardiovasculartissueengineering
‡A
A mesofluidics-based test platform for systematic development of scaffolds for in situ cardiovascular tissue engineering.
‡9
1
|
996
|
|
|
‡2
NTA|152190406
|
996
|
|
|
‡2
ISNI|0000000389779198
|
996
|
|
|
‡2
NTA|073636029
|
996
|
|
|
‡2
NTA|072049243
|
996
|
|
|
‡2
NTA|226746593
|
996
|
|
|
‡2
NTA|242094929
|
996
|
|
|
‡2
ISNI|000000039061207X
|
996
|
|
|
‡2
ISNI|0000000394972339
|
996
|
|
|
‡2
DNB|127941037
|
996
|
|
|
‡2
SUDOC|164473254
|
996
|
|
|
‡2
ISNI|0000000391004498
|
996
|
|
|
‡2
NTA|070087571
|
996
|
|
|
‡2
LC|no2023001241
|
996
|
|
|
‡2
NTA|074791672
|
996
|
|
|
‡2
NTA|327783257
|
996
|
|
|
‡2
LC|nr 89017564
|
996
|
|
|
‡2
NTA|073015148
|
996
|
|
|
‡2
SUDOC|130282898
|
996
|
|
|
‡2
NTA|067937640
|
996
|
|
|
‡2
NTA|074680471
|
996
|
|
|
‡2
SUDOC|103266526
|
996
|
|
|
‡2
NTA|143338412
|
996
|
|
|
‡2
SUDOC|181578212
|
996
|
|
|
‡2
ISNI|0000000394021357
|
996
|
|
|
‡2
NTA|271405228
|
996
|
|
|
‡2
ISNI|0000000423332892
|
996
|
|
|
‡2
ISNI|0000000391067798
|
996
|
|
|
‡2
ISNI|0000000390801639
|
996
|
|
|
‡2
ISNI|0000000396600133
|
996
|
|
|
‡2
NTA|074031716
|
996
|
|
|
‡2
NTA|108741214
|
996
|
|
|
‡2
NTA|391932179
|
996
|
|
|
‡2
NTA|080182046
|
996
|
|
|
‡2
ISNI|0000000395496151
|
996
|
|
|
‡2
NTA|431275718
|
996
|
|
|
‡2
ISNI|0000000394432666
|
996
|
|
|
‡2
ISNI|0000000391252571
|
996
|
|
|
‡2
NTA|304813710
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|